Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of adding ciprofloxacin ointment in treatment of cutaneous leishmaniasis
IRCT20130311012782N46Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Aug 2020
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ciprofloxacin in cutaneous leishmaniasis (CL), sponsored by Mashhad University of Medical Sciences. Started Aug 2020; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on IRCT20130311012782N46.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130311012782N46.